Degarelix is an active pharmaceutical ingredient used in hormonal therapy for prostate cancer. It functions as a gonadotropin-releasing hormone (GnRH) antagonist, reducing testosterone levels.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Degarelix?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Iturelix
pharmaceutical raw material
Deuruxolitinib phosphate
pharmaceutical raw material
Betamethasone valerate
pharmaceutical raw material
Selpercatinib
pharmaceutical raw material
(RS)-mianserin hydrochloride
pharmaceutical raw material
The international HS code for Degarelix (CAS 214766-78-6) is 2937.19.
2937.19
2937 19 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(4S)-N-[4-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2R)-1-amino-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-6-(propan-2-ylamino)hexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[4-(carbamoylamino)phenyl]-1-oxopropan-2-yl]amino]-3-oxopropyl]phenyl]-2,6-dioxo-1,3-diazinane-4-carboxamide
MEUCPCLKGZSHTA-XYAYPHGZSA-N
C[C@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCNC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC2=CC=C(C=C2)NC(=O)N)NC(=O)[C@H](CC3=CC=C(C=C3)NC(=O)[C@@H]4CC(=O)NC(=O)N4)NC(=O)[C@H](CO)NC(=O)[C@@H](CC5=CN=CC=C5)NC(=O)[C@@H](CC6=CC=C(C=C6)Cl)NC(=O)[C@@H](CC7=CC8=CC=CC=C8C=C7)NC(=O)C
Sourcing Degarelix?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.